Regulink’s Post

🧪 #FunFactFriday: Ever wonder about timelines? The entire drug development process can usually take 10 to 15 years, but #Phase1 trials are relatively swift, usually wrapping up in a few months. Expedient your early phase drug development process and save time on your next project. ⌛ 🔗 https://hubs.li/Q02GXqGn0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, #bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #genericdrugs #biotech #pharmaceuticalindustry

https://lnkd.in/dMXdG8cr One of the strategic initiatives of PSTP-II is to fulfill 60% national demand for essential medicines from local manufacturers by 2025. Hence, the Government of Ethiopia has been taking a multitude of tangible measures to encourage and capacitate local pharmaceutical manufacturers such as the arrangement of foreign currency required for the importation of Active Pharmaceutical ingredients (APIs), which is calculated from the verified Input-Output coefficient for each finished product. The assumption, here, is that locally manufactured essential medicines are more affordable and available than those imported which is exactly aligned with the mission of Ethiopian Pharmaceuticals Supply Service.

As most countries kick-start the preparations for the last quarter following the well-earned Summer break, here is a list of readings I found useful during this festive season: - Empowering MSLs to be the kings of Pharma’s New Frontier - Achieving Success in Scientific Exchange - Turning DOLs into KOLs – a new way to nurture influence in pharma - Field Medical Impact Measurement: A Biopharma Consensus and finally, the future of medical affairs in 2030 You can find an executive summary of those articles at: www.mymedicalaffairs.com #actionableinsights #work #msl #msls #team #pharmaceutical #medicalaffairs #futureofhealthcare

Trust your CRO partner as you trust your teammates. At BioPharma Services Inc. we have your back every step of the way, ensuring your clinical trials are handled with precision, care and professionalism. See what others are saying and let us be the partner you can rely on 👇 https://hubs.li/Q02L9Cny0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry #Paris2024

Now with Morisky Scale! From faster approvals to trusted care: We help empower pharma excellence, one dose at a time. CertiScan is a groundbreaking platform that revolutionizes the pharmaceutical industry by seamlessly integrating adherence, reconciliation, logistics, and brand insights into a unified cloud solution. CertiScan is the most powerful cloud platform in the business, offering unparalleled capabilities that cater to diverse pharmaceutical business units—from research to brand—with a focus on innovation and excellence. ### **Adherence and Reconciliation:** CertiScan ensures medication adherence by providing real-time monitoring and alerts for dosage administration, empowering patients to stay on track with their treatment. The platform excels in dose reconciliation, accurately tracking dosage distribution and consumption to eliminate discrepancies and enhance compliance. ### **Unmatched Connectivity:** CertiScan's connectivity is unrivaled, facilitating seamless integration with other business systems for comprehensive data analysis and insights. By connecting to various vendor platforms, CertiScan offers diverse pharmaceutical business units a versatile and scalable solution that enhances operational efficiency. ### **Revolutionizing Business Insights:** CertiScan transforms the way pharma unit leaders harness insights by consolidating adherence, reconciliation, coldchain, logistics, and brand insights capabilities in one robust platform. This empowers diverse pharmaceutical business units to optimize operations, make informed decisions, and drive growth through data-driven strategies. With CertiScan, trust in your drug supply chain is fortified by cutting-edge technologies, data-driven insights, and a patient-centric approach that connects you to your patients one dose, one tablet, one injection, at a time. De-risk your operations, enhance research, optimize logistics, and gain unparalleled brand insights with CertiScan—the ultimate solution for diverse pharmaceutical business units seeking to excel in today's competitive and complex market. www.certiscan.biz #clinicaltrials #drugsupply #Pharma #fda #digitalhealth #logistics #cfoinsights #smartpackaging #medicationadherence

The twin jet nozzle with a two-stage atomizing structure has the ability to produce a sub 10 μm particles. Check out this recent customer study showcasing the results. https://lnkd.in/eRyee_Xi Spray Dryer Line Up: https://lnkd.in/dk-i8pA #spraydrying #pharmaceutical #pharmaceuticals #pharmanews #pharmaceuticalindustry #pharmaindustry #osd #placebo #pharmaceuticalmanufacturing #gmp #pharmaceuticalsales #pharmamarketing #pharmamachinery #pharmaceuticalcompanies #drugdevelopment #cdmo #excipients #api #apidevelopment #agglomoration #granulation #tablets #capsules #formulation #dosage #processdevelopment

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dDfjNrTD The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

As the world gathers for the #Paris2024 Summer Olympics, BioPharma Services Inc. is inspired by the spirit of excellence and dedication. We wish all Olympians who strive for gold the best of luck! 🥇 Join us in celebrating the pursuit of perfection in sport and clinical research! Bring home results for your clinical projects. Click here 👇 https://hubs.li/Q02J7DB30 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry #Paris2024

The US Department of Justice’s recent move to reclassify cannabis as a less harmful Schedule III drug is the latest indication of the overall industry’s proliferation. As of 2024, the global cannabis market is projected to reach approximately $38.19 billion and is expected to grow at a CAGR of 14.6% between 2024 and 2028. This growth is fueled by continued legalization, technological advancements in cultivation and processing, and a growing body of research supporting the medical benefits of cannabis. However, marijuana is still federally outlawed, and as such, the list of intellectual property protections for marijuana businesses -- despite operating legally in their state -- is short. In our 2024 Cannabis Industry Report, we examine the science and classification of cannabis; the current nuances of banking, income tax, and regulations as they concern cannabis-related businesses; market and industry predictions, including key players; capital markets; and current activity in the cannabis patents space. To read the full report, visit: https://lnkd.in/ewjqmC6r #IntellectualProperty #Cannabis #CannabisIndustry